A detailed history of State Of Wyoming transactions in Cerus Corp stock. As of the latest transaction made, State Of Wyoming holds 93,352 shares of CERS stock, worth $168,033. This represents 0.02% of its overall portfolio holdings.

Number of Shares
93,352
Previous 122,262 23.65%
Holding current value
$168,033
Previous $215,000 24.65%
% of portfolio
0.02%
Previous 0.04%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.7 - $2.39 $49,147 - $69,094
-28,910 Reduced 23.65%
93,352 $162,000
Q2 2024

Aug 14, 2024

BUY
$1.62 - $2.04 $142,628 - $179,605
88,042 Added 257.28%
122,262 $215,000
Q1 2024

May 13, 2024

SELL
$1.66 - $2.42 $6,190 - $9,024
-3,729 Reduced 9.83%
34,220 $64,000
Q4 2023

Feb 14, 2024

BUY
$1.25 - $2.35 $20,972 - $39,428
16,778 Added 79.25%
37,949 $81,000
Q3 2023

Nov 14, 2023

SELL
$1.5 - $3.07 $9,925 - $20,314
-6,617 Reduced 23.81%
21,171 $34,000
Q2 2023

Aug 14, 2023

BUY
$1.79 - $2.9 $10,530 - $17,060
5,883 Added 26.86%
27,788 $68,000
Q1 2023

May 12, 2023

SELL
$2.65 - $3.81 $86,750 - $124,724
-32,736 Reduced 59.91%
21,905 $65,000
Q4 2022

Feb 14, 2023

BUY
$3.38 - $4.22 $126,192 - $157,553
37,335 Added 215.73%
54,641 $199,000
Q3 2022

Nov 14, 2022

BUY
$3.43 - $5.83 $28,650 - $48,697
8,353 Added 93.3%
17,306 $63,000
Q2 2022

Aug 15, 2022

BUY
$4.41 - $5.69 $5,697 - $7,351
1,292 Added 16.86%
8,953 $47,000
Q1 2022

May 13, 2022

BUY
$4.81 - $6.99 $7,258 - $10,547
1,509 Added 24.53%
7,661 $42,000
Q4 2021

Feb 11, 2022

SELL
$5.97 - $7.93 $1,098 - $1,459
-184 Reduced 2.9%
6,152 $42,000
Q3 2021

Feb 11, 2022

BUY
$4.79 - $6.68 $7,889 - $11,001
1,647 Added 35.12%
6,336 $39,000
Q2 2021

Feb 11, 2022

BUY
$5.35 - $6.35 $22,191 - $26,339
4,148 Added 766.73%
4,689 $28,000
Q1 2021

Feb 08, 2022

BUY
$5.68 - $7.87 $3,072 - $4,257
541 New
541 $3,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $319M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.